Aug 2026
Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.
Wen-Jun Xie, Mengran Tian, Weike Ma et al.
· Investigational new drugs · 0 citations